 |
Corporate News
31-Mar-14
|
|
|
|
|
|
|
|
|
|
|
|
Outcome of board meeting of Medicamen Biotech
|
|
Held on 31 March 2014
|
|
|
|
|
|
The Board of Medicamen Biotech in its meeting held on 31 March 2014, has allotted 4,23,606 equity shares at a price of Rs 11 per equity share (including a premium of Re 1 each), pursuant to Section 81(1A) of the Companies Act, 1956, the provisions of FEMA, 1999 and SEBI (ICDR) Regulations, 2009; and 9,47,300 warrants convertible into equity shares at a price of Rs 11 per warrant (including premium of Re 1), pursuant to Section 81(1A) of the Companies Act, 1956 and SEBI (ICDR) Regulations, 2009.
|
|
|
|
Previous News |
Medicamen Biotech standalone net profit rises 32.84% in the September 2018 quarter
(
Results
-
Announcements
14-Nov-18
16:21
)
|
|
|
Shivalik Rasayan authorises Medicamen Biotech to use DMF grade Bortezomib API
(
Corporate News
-
19-Jul-23
13:33
)
|
|
|
Medicamen Biotech to announce Quarterly Result
(
Corporate News
-
27-May-23
16:51
)
|
|
|
Medicamen Biotech standalone net profit rises 52.69% in the March 2019 quarter
(
Results
-
Announcements
07-Jun-19
17:03
)
|
|
|
Shiva Mills Ltd leads gainers in 'B' group
(
Hot Pursuit
-
29-Apr-24
12:15
)
|
|
|
Medicamen Biotech standalone net profit rises 53.33% in the December 2019 quarter
(
Results
-
Announcements
07-Feb-20
08:50
)
|
|
|
Medicamen Biotech standalone net profit declines 15.49% in the December 2018 quarter
(
Results
-
Announcements
12-Feb-19
16:41
)
|
|
|
Medicamen Biotech to list on NSE
(
Corporate News
-
26-Oct-21
13:27
)
|
|
|
Board of Medicamen Biotech recommends Final Dividend
(
Corporate News
-
29-Jun-21
12:51
)
|
|
|
Medicamen Biotech director resigns
(
Corporate News
-
29-Jan-20
18:31
)
|
|
|
Medicamen Biotech standalone net profit rises 64.16% in the December 2017 quarter
(
Results
-
Announcements
14-Feb-18
16:39
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|